CG Oncology Cash Flow Statement (2023-2025) | CGON

1Y3Y5Y7Y10YAll
Download Data
Cash Flow Statement Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025
Operating Activities
Net Income -8.68M-11.55M-11.76M-16.55M-16.93M-18.91M-20.40M-31.80M-34.46M-41.42M-43.71M
Depreciation and Depletion 0.10M0.50M
Share-based Compensation 0.18M0.18M0.39M0.78M1.52M2.25M2.65M4.99M5.15M7.01M7.33M
Gains from Investment Securities 0.00M7.72M7.71M0.86M
Non-cash Items 40.29M231.19M153.03M157.18M108.16M87.31M106.75M190.73M
Cash from Operations -7.99M-10.79M-12.26M-14.64M-26.01M-16.12M-15.92M-20.66M-29.30M-27.94M-38.89M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles 1.15M1.47M2.20M2.47M1.58M-1.25M0.28M1.89M-0.20M
Depreciation & Amortization (CF) 0.00M0.00M0.01M0.00M0.00M0.01M0.02M0.02M0.16M0.42M
Change in Working Capital
Change in Receivables -0.04M0.64M-0.44M0.22M0.24M
Change in Account Payables -0.01M0.05M0.59M1.38M1.42M-0.17M-0.41M2.44M0.21M0.39M1.23M
Change in Accured Expenses 0.16M0.77M1.45M1.76M-4.13M2.05M4.20M3.34M0.84M7.47M-3.38M
Investing Activities
Capital Expenditures 0.01M0.01M-0.00M0.21M0.02M0.01M0.10M
Change in Acquisitions & Divestments 30.66M230.04M145.87M170.13M201.24M228.18M200.14M170.38M251.38M
Cash from Investing Activities -78.70M103.36M-161.39M15.53M-307.44M-36.23M32.01M10.90M-186.77M1.41M15.04M
Financing Activities
Other financing activities -3.15M-3.39M-0.04M-0.23M-0.32M0.27M
Change in Capital Stock
Shares Issued 0.07M0.17M1.59M0.26M406.41M223.10M0.68M0.02M48.30M
Misc.
Cash from Financing Activities -0.77M-15.22M105.88M-2.90M402.66M0.04M2.17M223.41M0.45M-0.30M54.37M
Change in Cash -87.45M77.35M-67.77M-2.01M69.20M-52.31M18.25M213.66M-215.60M-26.85M30.52M
Beginning Cash Balance 87.45M-77.35M67.77M10.27M8.27M77.47M25.16M43.41M257.07M41.47M14.62M
Free Cash Flow -7.99M-10.79M-12.26M-14.64M-26.02M-16.13M-15.92M-20.87M-29.32M-27.95M-38.99M
Net Cash Flow -87.45M77.35M-67.77M-2.01M69.20M-52.31M18.25M213.66M-215.62M-26.82M30.52M